Delete search term

To content

Main navigation

Zurich University
of Applied Sciences

Service navigation

Catabolite Identification and Quantification

Description

Antibody-drug conjugates (ADC) are therapeutic monoclonal antibodies covalently conjugated to cytostatic agents featuring one of the new generation biopharmaceutical drugs for improved targeting of cancer cell killing. After receptor-mediated internalization of ADCs, the drugs are released and lead to cell death by interference with cellular structures. The goal of the project is the identification of the chemical nature of intracellular catabolites and the quantification thereof.

Key data

Project status

completed, 09/2023 - 09/2025

Institute/Centre

Institute of Chemistry and Biotechnology (ICBT)

Funding partner

Third party

Privacy Settings

Here we show you which services may run on our website. You decide for yourself which services we may use. You can find more information in our privacy notice.

Our website needs these cookies so that everything works properly. These cookies are created automatically when you are active on the site – for example, when you change privacy settings or fill in forms. You can block these cookies in your browser or set it to warn you about them, but some parts of the website will then no longer display correctly. These cookies do not store any of your personal data.

These services allow us to see how our website is used, but we do not know who you are. By activating these services, you help us make the website better for everyone.